Raju Kandimalla

Early translational lead for AR-LDD. Translational Oncology scientist with over 10 years of expertise in developing multi-omics-based tissue as well as cfNA (Cell-free nucleic acid) biomarkers at the pan-cancer level to enable early detection, prognosis (molecular subtypes), and therapeutic prediction. Led several biomarker studies in solid tumors from hypotheses generation to assay development us...